8-K - Vaxcyte, Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

. Other Events. Sales Agreement On February 24, 2026, Vaxcyte, Inc. (“ Vaxcyte ”) entered into a sales agreement (the “ Sales Agreement ”) with Leerink Partners

Other Event

$500.0M

9.01

. Financial Statements and Exhibits. Exhibit Number Description 1.1 Sales Agreement, dated February 24, 2026, between the Company and the Placement Agent 5.1 Op

Exhibits Only

Exhibits (3)

1.1

EX-1.1

5.1

EX-5.1

8-K